Dimension Therapeutics, Inc. Net Income
Dimension Therapeutics, Inc. reported Net Income of -$16.95 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2017-11-06
- Dimension Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2017-09-30 was -$16.95M.
- Dimension Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2017-06-30 was -$12.31M.
- Dimension Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2017-03-31 was -$13.49M.
- Dimension Therapeutics, Inc. net income (loss) attributable to parent for the quarter ending 2016-12-31 was -$13.03M.
- Dimension Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2016 was -$49.00M.
- Dimension Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2015 was -$35.06M.
- Dimension Therapeutics, Inc. net income (loss) attributable to parent for fiscal 2014 was -$12.97M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$16.95M 10-Q · filed 2017-11-06 | -$29.26M derived: sum of 2 quarters · filed 2017-11-06 | -$42.75M 10-Q · filed 2017-11-06 | -$55.77M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-06-30 | -$12.31M 10-Q · filed 2017-08-08 | -$25.80M 10-Q · filed 2017-08-08 | -$38.83M derived: sum of 3 quarters · filed 2017-08-08 | -$53.19M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-03-31 | -$13.49M 10-Q · filed 2017-05-10 | -$26.52M derived: sum of 2 quarters · filed 2017-05-10 | -$40.88M derived: sum of 3 quarters · filed 2017-11-06 | -$52.98M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-12-31 | -$13.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$27.39M derived: sum of 2 quarters · filed 2017-11-06 | -$39.49M derived: sum of 3 quarters · filed 2017-11-06 | -$49.00M 10-K · filed 2017-03-09 |
| 2016-09-30 | -$14.37M 10-Q · filed 2017-11-06 | -$26.46M derived: sum of 2 quarters · filed 2017-11-06 | -$35.98M 10-Q · filed 2017-11-06 | -$45.00M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-06-30 | -$12.10M 10-Q · filed 2017-08-08 | -$21.61M 10-Q · filed 2017-08-08 | -$30.64M derived: sum of 3 quarters · filed 2017-08-08 | -$41.31M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | -$9.51M 10-Q · filed 2017-05-10 | -$18.54M derived: sum of 2 quarters · filed 2017-05-10 | -$29.21M derived: sum of 3 quarters · filed 2017-05-10 | -$39.18M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | -$9.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$19.70M derived: sum of 2 quarters · filed 2017-03-09 | -$29.67M derived: sum of 3 quarters · filed 2017-03-09 | -$35.06M 10-K · filed 2017-03-09 |
| 2015-09-30 | -$10.67M 10-Q · filed 2016-11-10 | -$20.64M derived: sum of 2 quarters · filed 2016-11-10 | -$26.03M 10-Q · filed 2016-11-10 | -$30.64M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | -$9.97M 10-Q · filed 2016-08-11 | -$15.36M 10-Q · filed 2016-08-11 | -$19.98M derived: sum of 3 quarters · filed 2017-03-09 | -$22.46M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | -$5.39M 10-Q · filed 2016-05-12 | -$10.01M derived: sum of 2 quarters · filed 2017-03-09 | -$12.49M derived: sum of 3 quarters · filed 2017-03-09 | |
| 2014-12-31 | -$4.62M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$7.10M derived: sum of 2 quarters · filed 2017-03-09 | -$12.97M 10-K · filed 2017-03-09 | |
| 2014-09-30 | -$2.48M 10-Q · filed 2015-12-04 | -$8.35M 10-Q · filed 2015-12-04 | ||
| 2013-12-31 | -$3.17M 10-K · filed 2016-03-24 |